We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Welcome to the Dasatinib-Teva® Patient Portal

Dasatinib-Teva^®

Resources for patients treated with Dasatinib-Teva^®

20mg, 50mg, 70mg, 100mg tablets

You have access to this website because your doctor has prescribed Dasatinib-Teva for you.

Dasatinib-Teva is used to treat certain types of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL).

These resources will help you understand why you are using Dasatinib-Teva, how it works, how to use it and possible side effects you may or may not experience.

If you have any concerns about your treatment or condition, please talk to your doctor.

Patient Resources

Please click on the links below to access some of our available resources

My Dasatinib-Teva® Handbook

Product Information

Consumer Medicine Information

Welcome to Dasatinib-Teva®

This portal is intended for patients who have already been prescribed Dasatinib-Teva^® (dasatinib) and healthcare professionals (HCPs). By accepting this disclaimer, you confirm that you have recently been prescribed Dasatinib-Teva^®or are currently being treated with Dasatinib-Teva^®or are a HCP. The resources here are a guide to assist with your Dasatinib-Teva^®therapy. If you are a patient and require medical advice, you should refer to your treating doctor.

Patients: When you click on 'Accept' below, you will be prompted to enter the barcode numbers shown on the reverse of your Dasatinib-Teva^® pack. For any further questions, please contact medinfo.anz@tevapharm.com or call 1800 288 382.

Healthcare Professionals: If you are a HCP, enter your AHPRA number. For any further questions or support, please contact medinfo.anz@tevapharm.com or your Teva representative.